Position in MLYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$32,963,030
+$18,733,737 QoQ
Shares Held
1,221,758
+132.6% QoQ
Ownership
1.38%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#24
of 224 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MLYS Over Time
Shares Held
Position Value (USD)
Derivatives in MLYS
reported options exposure · as of Jun 30, 2026CallValue
$841,776
CallShares
31,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,595,633,334 across 322 Biotechnology names. MLYS ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in MLYS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $841,776 | 31,200 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $32,963,030 | 1,221,758 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $14,229,293 | 525,260 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,165,250 | 225,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $2,853,301 | 78,625 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,342,014 | 404,589 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,295,488 | 243,569 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $903,572 | 56,900 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $6,744,093 | 424,691 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,561,606 | 1,101,674 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,195,656 | 98,733 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $766,794 | 65,538 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $482,059 | 37,340 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,274,527 | 380,759 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,464,901 | 364,343 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||